We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. On the regional level, as the Human Development Index ...
Researchers have shown that the IGFBP3 protein plays a relevant role in human lung development. The results of the study, which used organoids derived from embryonic lungs, open up new perspectives on ...
The lung is a highly specialised organ that develops through a complex series of branching events and cellular differentiation processes. From the initial budding of the foregut, the formation of ...
Researchers of the University of Barcelona and the August Pi y Sunyer Biomedical Research Institute (IDIBAPS) have shown that the IGFBP3 protein plays a relevant role in human lung development. The ...
Lung development and function is notoriously difficult to study. Both are affected by a range of environmental factors, such as first- and second-hand smoke, air pollution, and infections and genetic ...
“In this study, we investigated the interplay between cigarette smoke, DNA damage and repair, focusing on the Nucleotide Excision Repair (NER) protein Xeroderma Pigmentosum Group C (XPC).” “In this ...
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
An abnormal BMI in children -- be it high or low -- can now be associated with impaired lung function, but if their BMI is normalized before they reach adulthood, the impairment can be offset, ...
Here's another good reason to help your child reach and maintain a healthy weight: A new study warns that kids who are either too skinny or too fat are at risk for impaired lung function. However, if ...
iTeos Therapeutics announced that the GALAXIES Lung-201 Phase 2 trial, assessing the combination of belrestotug and dostarlimab for lung cancer, did not meet the criteria for clinically meaningful ...
Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its potential to improve treatment outcomes. The designation is based on phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results